The Food and Drug Administration banned Red Dye No. 3 on Wednesday, Jan. 15, after scientists confirmed that the ingredient ...

The Centers for Medicare and Medicaid Services (CMS) identified 15 drugs it has selected for price negotiations with drug ...

Maintaining oral health is crucial for overall well-being, yet many individuals overlook the importance of proper dental care ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

Hikma said on Monday it was “pleased to have FDA approval to launch this important medicine and to provide broader access and greater affordability for the patients who rely on it”.

The FDA approved several drugs in December for the treatment of diseases, including pancreatic adenocarcinoma, lung cancer, skin cancer and graft-versus-host disease. Throughout December, the Food and ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could be used for in adults and children 10 and up. The new drug ...

The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide, was previously approved as Mounjaro to treat Type 2 diabetes and became popular as an off ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.

The U.S. Food and Drug Administration (FDA) has approved 20 ZYN nicotine "pouch" products for sale after what it called "a thorough review." These nicotine pouches are small fiber pouches ...